Table 2.
Outcomes | Objective response rate, n (%) |
---|---|
Best overall response | 9 (17.3%) |
Complete response | 2 (3.8%) |
Partial response | 7 (13.5%) |
Stable disease | 26 (50%) |
>6 months | 15 (29%) |
<6 months | 11 (21%) |
Progressive disease | 17 (32.7%) |
Clinical benefit | 24 (46%) |